UK markets closed

GlycoMimetics, Inc. (GLYC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0000-0.1800 (-5.66%)
As of 01:12PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 203.48M
Enterprise value 155.09M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)824.28
Price/book (mrq)4.37
Enterprise value/revenue 555.40
Enterprise value/EBITDA -3.86

Trading information

Stock price history

Beta (5Y monthly) 2.18
52-week change 3154.40%
S&P500 52-week change 329.57%
52-week high 33.5300
52-week low 31.1100
50-day moving average 32.9942
200-day moving average 32.0101

Share statistics

Avg vol (3-month) 3346.27k
Avg vol (10-day) 3367.12k
Shares outstanding 564.39M
Implied shares outstanding 664.39M
Float 840.29M
% held by insiders 13.05%
% held by institutions 153.54%
Shares short (29 Feb 2024) 41.56M
Short ratio (29 Feb 2024) 44.8
Short % of float (29 Feb 2024) 43.48%
Short % of shares outstanding (29 Feb 2024) 42.42%
Shares short (prior month 31 Jan 2024) 4997.93k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-46.15%
Return on equity (ttm)-80.42%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -40.13M
Net income avi to common (ttm)-38.07M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)49.41M
Total cash per share (mrq)0.77
Total debt (mrq)1.01M
Total debt/equity (mrq)2.17%
Current ratio (mrq)8.14
Book value per share (mrq)0.72

Cash flow statement

Operating cash flow (ttm)-35.18M
Levered free cash flow (ttm)-22.92M